Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Pfizer Limited
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 27/02/2012
PIL VFEND 40mg/ml powder for oral suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 27/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
Updated on 09/01/2012 and displayed until 27/02/2012
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to, or new, use for medicine
  • Change to dosage and administration
Updated on 13/09/2011 and displayed until 09/01/2012
Reasons for adding or updating:
  • Change to drug interactions
Updated on 17/01/2011 and displayed until 13/09/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 14/09/2010 and displayed until 17/01/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 24/02/2009 and displayed until 14/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 12/05/2008 and displayed until 24/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 21/02/2008 and displayed until 12/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to date of revision
Updated on 25/07/2007 and displayed until 21/02/2008
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
  • Change to warnings or special precautions for use
  • Change to Further Information section
  • Change to date of revision
  • PIL Retired combination of strengths
Updated on 14/06/2007 and displayed until 25/07/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
  • Improved Electronic Presentation
  • Change to dosage and administration
  • Change to how to administer the medicine
  • Change of special precautions for disposal
Updated on 26/09/2006 and displayed until 14/06/2007
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 07/08/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Change to drug interactions
Updated on 28/07/2006 and displayed until 07/08/2006
Reasons for adding or updating:
  • PIL Retired pending re-submission
  • Change to drug interactions
Updated on 01/03/2006 and displayed until 28/07/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to side-effects
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 31/05/2005 and displayed until 01/03/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  voriconazole